Clinical Trial Update: Treatment of Rett Syndrome With Recombinant Human IGF-1 [Phase 2]

View source ↗

Summary

A Phase 2 trial of recombinant human insulin-like growth factor-1 (IGF-1) for Rett syndrome has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• recombinant human insulin-like growth factor-1 (IGF-1) (insulin-like growth factor-1)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Rett Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-03-26